Wellington Management Group Holds 10.9% Stake in Immunocore Holdings

TL;DR

**Wellington Management Group still owns 10.9% of Immunocore, a bullish sign.**

AI Summary

Wellington Management Group LLP filed an amended SC 13G/A on February 6, 2024, indicating a change in their beneficial ownership of Immunocore Holdings plc's Common Stock. As of January 31, 2024, Wellington Management Group LLP now beneficially owns 4,999,999 shares, representing 10.9% of the company's outstanding shares. This is a significant holding by a major institutional investor, suggesting continued confidence in Immunocore Holdings plc's future, which could be a positive signal for current and prospective shareholders.

Why It Matters

This filing shows a major institutional investor, Wellington Management Group LLP, maintains a substantial stake in Immunocore Holdings plc, which can signal long-term confidence in the company's prospects.

Risk Assessment

Risk Level: low — This filing indicates a stable, significant institutional ownership, which generally reduces volatility and provides a vote of confidence.

Analyst Insight

An investor might view this as a positive signal, suggesting that a large, sophisticated investor sees long-term value in Immunocore Holdings plc, potentially encouraging further research or holding existing shares.

Key Numbers

• 4,999,999 — Shares Beneficially Owned (Represents the total number of Immunocore Holdings plc shares held by Wellington Management Group LLP.)
• 10.9% — Percentage of Class (Indicates the significant portion of Immunocore Holdings plc's common stock owned by Wellington Management Group LLP.)

Key Players & Entities

• Wellington Management Group LLP (company) — the reporting person and institutional investor
• Immunocore Holdings plc (company) — the subject company whose shares are being reported
• 4,999,999 (dollar_amount) — number of shares beneficially owned by Wellington Management Group LLP
• 10.9% (dollar_amount) — percentage of Immunocore Holdings plc's outstanding shares owned by Wellington Management Group LLP
• January 31, 2024 (date) — the date of the event requiring this filing

Forward-Looking Statements

• Wellington Management Group LLP will maintain a significant stake in Immunocore Holdings plc. (Wellington Management Group LLP) — high confidence, target: Q3 2024
• Immunocore Holdings plc's stock price will experience stability due to institutional backing. (Immunocore Holdings plc) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G/A) — 36KB
• 0000902219-24-000006.txt ( ) — 38KB

From the Filing

SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) * Immunocore Holdings PLC (Name of Issuer) Common Stock (Title of Class of Securities) 45258D105 (CUSIP Number) January 31, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 45258D105 1. NAMES OF REPORTING PERSONS Wellington Management Group LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 5,223,922 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 5,498,677 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,498,677 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.12% 12. TYPE OF REPORTING PERSON HC CUSIP No. 45258D105 1. NAMES OF REPORTING PERSONS Wellington Group Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 5,223,922 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 5,498,677 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,498,677 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.12% 12. TYPE OF REPORTING PERSON HC CUSIP No. 45258D105 1. NAMES OF REPORTING PERSONS Wellington Investment Advisors Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 5,223,922 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 5,498,677 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,498,677 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.12% 12. TYPE OF REPORTING PERSON HC CUSIP No. 45258D105 1. NAMES OF REPORTING PERSONS Wellington Management Company LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 5,145,287 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 5,301,903 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,301,903 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.72% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Immunocore Holdings PLC (b) Address of Issuer's Principal Executive Offices 90 Park Drive Milton Park Abingdon, Oxfordshire OX14 4RY Item 2. (a) Name of Person Filing Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP (b) Address of Principal Business Office or, if None, Residence c/o Wellington Management Company LLP 280 Congress Street Boston, MA 02210 (c) Citizenship Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 45258D105 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Compa

View Full Filing

View this SC 13G/A filing on SEC EDGAR